Advancing Cancer Care for Dogs
We are transforming canine cancer care through ongoing scientific research and innovation in therapeutic treatments.
Peer Reviewed by Nature™: Remarkable Survival Gains for Canine Cancer Patients. See how we work with:
![](https://fidocure.com/wp-content/uploads/2023/06/Nature_journal_logo-removebg-preview.png)
New approaches to the development of cancer therapeutics are urgently needed to improve the current 89% failure rate of novel drugs in clinical trials, and to improve patient outcomes. Spontaneous cancer in companion animals represents a unique opportunity for investigation of novel therapeutics for human and veterinary use
![](https://fidocure.com/wp-content/uploads/2023/06/the-washington-post3353-removebg-preview-e1687444975245.png)
Dog cancer research advances pursuit of drugs for humans and canines
Published June 19, 2023 | Compelling genetic data, increased funding and growing collaborations in the past decade are pushing forward development of cancer drugs for both canines and humans
![](https://fidocure.com/wp-content/uploads/2023/06/POLITICOLOGO-2.png)
Could Fido lead us to better cancer drugs?
Despite a growing number of targeted cancer treatments in development each year, few are able to reach cancer patients due to the rate at which evidence is generated from human clinical trials
![](https://fidocure.com/wp-content/uploads/2023/06/TCL_Logo-trans-e1560875829401.png)
World’s largest genomic study of canine cancer reveals potential for novel human cancer treatments
Researchers from Stanford AI Health and One Health, the world’s first translational canine cancer care company, published the results from the largest-ever genomic study of canine cancer which revealed a promising path for enhanced human cancer treatments.
![](https://fidocure.com/wp-content/uploads/2023/04/dr-rob-proietto-b.png)
There’s no “one-size-fits-all” treatment for cancer. That’s why FidoCure® uses genomic testing to determine the best course of action for your dog’s cancer therapy – beyond standard chemo and radiation.
Precision medicine can offer a hopeful prognosis. FidoCure® was created by dog lovers and scientists on a mission to make effective canine cancer treatment accessible. Our process uses genomic testing in conjunction with tumor type to identify possible cancer-causing mutations. From there, we suggest targeted therapy to precisely attack the cancer cells.
Forrest was diagnosed with splenic cancer and given one month to live.
Through the targeted therapy suggested by FidoCure®, he lived happily for nearly 4 years past his diagnosis.
![](https://fidocure.com/wp-content/plugins/elementor/assets/images/placeholder.png)
![](https://fidocure.com/wp-content/uploads/2023/05/forrest-2.png)
Forrest, Golden Retriever
Hemophagocytic Histiocytic Sarcoma
Trusted by the Leading Veterinary Oncologists
![](https://fidocure.com/wp-content/plugins/elementor/assets/images/placeholder.png)
Thousands of dogs have benefitted from FidoCure® when other options were limited.
![](https://fidocure.com/wp-content/uploads/2023/05/toulouse-1.png)
Toulouse
“Since starting treatment, Toulouse’s tumors have regressed. FidoCure® brought us hope for Toulouse when we thought we didn’t have any options left.” — Daniel, FL
![](https://fidocure.com/wp-content/uploads/2023/05/lizzie-1.png)
Lizzie
“Thanks to FidoCure®, Lizzie is 100% active again, eating well, and in remission for 5 months.” — Kimberley and Francois, CT
![](https://fidocure.com/wp-content/uploads/2023/04/Gracie_Gonzalez_1.jpg)
Gracie
“[Our vet] told us about the One Health Company’s precision medicine solution, FidoCure®… Now, exactly two months later, Gracie’s cancer is in remission.” — The Gonzalez Family, FL
Resources & Education
-
How Does FidoCure Work?
by FidoCure
FidoCure is pioneering a revolutionary approach to treating canine cancer - bringing the power of precision medicine from human oncology to […]
-
Vet Optimist Podcast: Interview with CEO Christina K. Lopes and Jennifer Evans
by Christina K. Lopes
We are excited to share an inspiring and insightful episode of "The Veterinary Optimist" podcast, featuring our very own Christina Lopes, […]
-
Companion Animal Science Takes Center Stage: Insights from The New York Times
by Christina K. Lopes
A recent article in The New York Times, titled, "How science went to the dogs (and cats)," highlights the remarkable evolution of companion […]
-
Precision Medicine for Canine Mammary Gland Tumors
by FidoCure
Mammary tumors are common in intact female dogs, especially middle-aged and older dogs of smaller breeds like Poodles, Chihuahuas, and […]
-
Histiocytic Sarcoma: One of the Most Aggressive Cancers
by FidoCure
Histiocytic sarcoma (HS) is an aggressive cancer originating from white blood cells called histiocytes that are involved in the immune […]
-
Canine Melanoma: A Common, Aggressive Malignancy
by FidoCure
Melanoma is an aggressive cancer arising from pigment-producing cells, accounting for 7% of canine tumors with certain breeds at higher […]